[{"address1": "302, 6 Butler Street", "city": "Camberwell", "state": "VIC", "zip": "3124", "country": "Australia", "phone": "61 3 9882 0780", "fax": "61 3 9882 9969", "website": "https://www.propanc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Propanc Biopharma, Inc., a biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research collaboration with University of Ja\u00e9n to carry out a research project aimed at the synthetic development of PRP and its subsequent validation; and a joint research and drug discovery program with Universities of Ja\u00e9n and Granada for the POP1 program to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Nathanielsz", "age": 50, "title": "Executive Chairman, CEO, CFO, Treasurer & Secretary", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 548527, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julian Norman Kenyon ChB, M.D., MB", "age": 76, "title": "Chief Scientific Officer, CTO & Director", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 36142, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Klaus  Kutz M.D.", "title": "Chief Medical Officer & Member of Scientific Advisory Board", "fiscalYear": 2024, "totalPay": 18229, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.6, "open": 4.75, "dayLow": 4.75, "dayHigh": 5.92, "regularMarketPreviousClose": 4.6, "regularMarketOpen": 4.75, "regularMarketDayLow": 4.75, "regularMarketDayHigh": 5.92, "payoutRatio": 0.0, "beta": 18837.52, "volume": 501, "regularMarketVolume": 501, "averageVolume": 2238, "averageVolume10days": 2150, "averageDailyVolume10Day": 2150, "bid": 4.75, "ask": 5.92, "bidSize": 2031, "askSize": 199, "marketCap": 68741856, "fiftyTwoWeekLow": 0.0004, "fiftyTwoWeekHigh": 145.46, "fiftyDayAverage": 4.536542, "twoHundredDayAverage": 3.4967015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 69938160, "profitMargins": 0.0, "floatShares": 2404452, "sharesOutstanding": 11611800, "heldPercentInsiders": 0.71476996, "heldPercentInstitutions": 0.07751, "impliedSharesOutstanding": 12876200, "bookValue": 1.558, "priceToBook": 3.7997434, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -55210416, "trailingEps": -333.31, "lastSplitFactor": "1:2", "lastSplitDate": 1738108800, "enterpriseToEbitda": -1.298, "52WeekChange": 3287.889, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 5.92, "recommendationKey": "none", "totalCash": 50760, "totalCashPerShare": 0.004, "ebitda": -53892560, "totalDebt": 1247170, "quickRatio": 0.013, "currentRatio": 2.243, "debtToEquity": 6.893, "returnOnAssets": -2.9854598, "returnOnEquity": -7.67196, "freeCashflow": -95819592, "operatingCashflow": -637948, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PPCB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "shortName": "Propanc Biopharma, Inc.", "longName": "Propanc Biopharma, Inc.", "corporateActions": [], "regularMarketTime": 1753401600, "regularMarketChangePercent": 28.695656, "regularMarketPrice": 5.92, "exchange": "PNK", "messageBoardId": "finmb_134729532", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -333.31, "fiftyDayAverageChange": 1.3834581, "fiftyDayAverageChangePercent": 0.30495873, "twoHundredDayAverageChange": 2.4232986, "twoHundredDayAverageChangePercent": 0.69302416, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1357569000000, "regularMarketChange": 1.3200002, "regularMarketDayRange": "4.75 - 5.92", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 2238, "fiftyTwoWeekLowChange": 5.9196, "fiftyTwoWeekLowChangePercent": 14799.0, "fiftyTwoWeekRange": "4.0E-4 - 145.46", "fiftyTwoWeekHighChange": -139.54001, "fiftyTwoWeekHighChangePercent": -0.95930153, "fiftyTwoWeekChangePercent": 328788.9, "dividendDate": 1605744000, "displayName": "Propanc Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]